Sight Sciences - a company that manufactures medical and surgical devices for eye diseases treatment, has priced its initial public offering (IPO) and hoping to raise up to $160.54M.

  • Detailed instructions how to participate in Sight Sciences (pre-IPO, offering price) see belowπŸ‘‡
Sight Sciences Initial Public Offering
Sight Sciences Initial Public Offering

What is an IPO and how it works

IPO is a process of offering shares of a private corporation to the public in a new stock issuance. Why go public? The primary benefit of going public is easier access to capital.

To go public, a company must have a track record of growth and other favorable results and hire an investment bank (Morgan Stanley/ BofA Securities/ Citigroup/ Piper Sandler in Sight Sciences case) to come in and underwrite the IPO. The underwriters also performed due diligence and verified financial information and business model.

Once the paperwork done, the company sells the stock to institutional investors. When the initial block of shares has been sold, the company with underwriters' help sets an initial price and date for the stock to begin trading on a stock exchange.

Company Profile and Financial Indicators before Sight Sciences IPO

Sight Sciences (SGHT), a company that manufactures medical and surgical devices for eye diseases treatment, is launching its IPO in the NASDAQ on July 14.

Sight Sciences produces two types of devices, namely, the OMNI surgical system and the TearCare system. The OMNI is a portable therapy device that allows ophthalmic surgeons to reduce intraocular pressure in adult patients with glaucoma, while also minimizing surgical intervention. TearCare is a device for treatment of dry eye syndrome by locally heating the eyelids.

OMNI was first approved by the US's FDA in 2017, and currently has 50 patents. In 2021,it became the first FDA-approved microinvasive glaucoma surgery (MIGS) device. As the company management reports, OMNI is the most efficient device for performing corneal surgeries.

Sight Sciences products have good potential in the ophthalmic device market. Primary open-angle glaucoma affects more than 4 million people in the United States, while the total number of cases worldwide, according to WHO, is about 70 million people. At the same time, the total potential market for Sight Sciences is estimated at $16 billion.

Market Cap $908.38mil
Revenues $29.7 mil (last 12 months)
Net Income $-37.7 mil (last 12 months)

How to Buy Sight Sciences Stocks Before the IPO (Offering Price)

In the past, IPOs as highly profitable investments were available only to the privileged customers of the leading brokerage firms and it was challenging for retail investors to gain access. You couldn't buy shares paying the price set by the company and you had to wait until the shares actually start trading on the public stock market at whatever stock price supply and demand allows.

Technologies and marketplaces changed the rules of the game, now regular investors can get pre-IPO shares. To participate in Sight Sciences IPO you need to use an IPO investing app like Freedom Finance (NASDAQ: FRHC), TD Ameritrade or Fidelity. They give its customers access to IPOs and secondary offerings through their existing brokerage account. Also you can buy Sight Sciences shares when the company goes public via a commission-free trading app like Webull.

🚨 Detailed Instructions How to Participate in the Sight Sciences IPO before public trading:

Below we share the instruction how to participate in the approaching Sight Sciences IPO using Freedom Finance (Freedom24 platform). Β This marketplace is chosen as an example because Sight Sciences is already listed there.

🎁 Special limited time offer for European Union citizens or residents aged at least 25 years - you will get a free share when you open a new account through this link. The value of a stock that you will receive in your account may vary in the range of USD $600, with companies like Netflix, Ford, Microsoft etc.

*** Freedom Finance services are NOT available to US citizens and residents.

  1. Apply for a Freedom Finance account β€” you need to prepare your identity document and a document confirming the address of residence (utility bill). The verification process is very fast, it will take 2 minutes to create your account.
  2. Deposit your account β€” to participate in an IPO, your account must have available funds in the amount you send IPO application for.
  3. πŸ’‘ Tip: It's recommended to deposit your account in advance. Often the exact IPO date is undefined until the last day. You may have a short notice for participation and account deposits also takes time for processing. Also, sometimes Freedom sends last-minute IPO offer when you have 2 hours to participate.
  4. Submit a request to participate in the IPO β€” when applications are open select Sight Sciences and click Participate in the IPO > input the amount you want to invest > Send your application. Note: Before the book closing, a request can be withdrawn. At the time of the book closing, 1 day before the start of the exchange trading, the specified amount will be blocked on the account.
  5. Wait for allocation β€” The actual number of stocks purchased during an IPO depends on supply and demand. The higher underwriter reserves the right to partial execution of collective applications. So if the demand is high you may get less than you applied for. Of course, you will only pay for the shares purchased. The rest of the funds will be returned to your account.
  6. Start of trading β€” With the beginning of the public trading on the stock exchange, the purchased shares will appear on the account and a lock-up period will start β€” a 93-day period of prohibition on sale. You can’t sell stocks, but you can track their current value and growth indicators in your personal member area and a trading terminal.
  7. Closing your trade β€” At the end of the 93 days lock-up period, you will be able to manage your stocks at your discretion β€” leave in the portfolio or sell and withdraw money or transfer the stocks to another depository/ broker in your name. This can be done in your account by clicking the β€˜Sell’ button next to the name of the security. In this case, a commission of 0.5% of the amount of the sale transaction is charged.
Participate in Sight Sciences IPO

Is investing in IPOs profitable?

Not always. The average return at the end of the lock-up period is 72%, past IPOs data.

When is the Sight Sciences IPO date?

Sight Sciences's IPO date is July 13, 2021.

What is Sight Sciences IPO price range?

Sight Sciences Β IPO price range is $20 - $23 per share.

How to Invest in Sight Sciences after the IPO date (opening price)?

After the IPO you can buy Sight Sciences stocks via Freedom24 or Webull on the first trading day.

In what currency Sight Sciences IPO and post-IPO shares will be traded?

The Sight Sciences IPO and stock trading currency will be USD.

If you have funds in another currency the cheapest way to convert your currency is to use the mid-market rate (that’s the one you’ll find on Google) which can be done via a fintech service like Wise. Banks may add hidden markups to their exchange rates - charging you more without your knowledge. And if they have a fee, they charge you twice. Wise never hides fees in the exchange rate.

What is the Sight Sciences (stock symbol)

The stock ticker for Sight Sciences will be SGHT

Sight Sciences Registration Statement on Form S-1

Sight Sciences Registration Statement on Form S-1

IPO Calendar 2021
IPOs this week and upcoming 2021

This page may contain affiliate links.